Speakers: Angela Lamb, MD, FAAD and Naiem T. Issa, MD, PhD, FAAD

Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY

Please join us for our next IDF Educational Series Webinar: Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies. Skin Deep: Atopic Dermatitis in Women. Sex-Specific Considerations in Diagnosis, Triggers & Management Dr. Angela Lamb will review the epidemiology and pathophysiology of atopic dermatitis in women, highlighting the influence of hormonal changes, psychosocial stressors, cosmetics, occupational exposures, and reproductive milestones on disease activity. The session will provide practical, evidence-based guidance for managing atopic dermatitis in sensitive areas, including the face, eyelids, nipple/areola, and vulvar region, while discussing treatment considerations for pregnancy, lactation, menopause, and women of reproductive age. EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients? Join your colleagues for a peer discussion exploring the latest EBGLYSS data. This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

REGISTER HERE